Amber Angles
Family Medicine · Delta, CONPI 1407205966
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.6% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$638
- GSK$511
- Astellas Pharma US Inc$358
- AstraZeneca$326
- Pfizer$197
- Lilly USA, LLC$177
- plus $470 from 13 others
What the payments were for
- Food & beverage$2,58597%
- Education$913%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 46 | $638 |
| GSK | 23 | $511 |
| Astellas Pharma US Inc | 12 | $358 |
| AstraZeneca | 19 | $326 |
| Pfizer | 11 | $197 |
| Lilly USA, LLC | 11 | $177 |
| Exact Sciences | 5 | $92 |
| Edwards Lifesciences | 2 | $78 |
| Amgen(2 entities) | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| Johnson & Johnson | 2 | $34 |
| Organogenesis Inc. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Novo Nordisk | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Bayer | 1 | $15 |
| Medtronic | 1 | $13 |
How this compares
$2,676 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 63 | $87,020 |
| OzempicSemaglutide | 37 | $50,793 |
| FarxigaDapagliflozin Propanediol | 27 | $32,310 |
| XareltoRivaroxaban | 25 | $30,270 |
| VraylarCariprazine Hcl | 14 | $23,922 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 13 | $16,767 |
| LinzessLinaclotide | 17 | $13,200 |
| EliquisApixaban | 19 | $12,045 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 14 | $6,953 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 42 | $6,446 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $5,412 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $4,028 |
| Pantoprazole Sodium | 84 | $3,912 |
| OxycontinOxycodone Hcl | 11 | $3,570 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $1,948 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $177 | $87,02063 claims |
| Novo NordiskOzempic | $19 | $50,79337 claims |
| AbbVieVraylar, Linzess, Armour Thyroid, Synthroid | $638 | $39,885103 claims |
| AstraZenecaFarxiga, Symbicort | $326 | $37,72243 claims |
| Johnson & JohnsonXarelto | $34 | $30,27025 claims |
| GSKTrelegy Ellipta | $511 | $16,76713 claims |
| PfizerEliquis | $197 | $12,04519 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Delta
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Matthew YoungColorado Springs$270K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
- Michael MeekerUsaf Academy$174K
- Carolynn Francavilla BrownLakewood$174K
- Lawrence AndrewsColorado Springs$102K
- Gregory MaederWestminster$95K
- Paul SimmonsGrand Junction$62K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.